Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
REVERSE IMMUNIZATION
Show more
Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders; Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of recombinant proteins; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders by modulating the immune system by recombinant proteins that contain a targeting moiety and an effector moiety t…
Class 5 – Pharmaceuticals & supplements
Status timeline
- 12 Jul 2021Application filedNew Application Entered
- 28 Mar 2022Assigned to an examining attorneyAssigned To Examiner
- 6 Apr 2022Office action issuedNon-Final Action Written
- 28 Sep 2022Response to office action filedTeas Response To Office Action Received
- 15 Feb 2023Final refusal issuedFinal Refusal Mailed
- 3 Jul 2023Approved for registration (Supplemental Register)Approved For Registration Supplemental Register
- 30 Jan 2024Registered on the Supplemental RegisterRegistered-Supplemental Register
All 30 events
| 2024-01-30 | Registered-Supplemental Register |
| 2024-01-30 | Notice Of Registration Confirmation Emailed |
| 2023-12-28 | Electronic Record Review Complete |
| 2023-12-22 | On Hold - Electronic Record Review Required |
| 2023-07-03 | Approved For Registration Supplemental Register |
| 2023-05-25 | Teas Request For Reconsideration Received |
| 2023-05-25 | Correspondence Received In Law Office |
| 2023-05-25 | Teas/Email Correspondence Entered |
| 2023-05-23 | Teas Change Of Owner Address Received |
| 2023-05-23 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2023-05-23 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2023-05-23 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2023-05-23 | Teas Change Of Domestic Representatives Address |
| 2023-05-23 | Teas Change Of Correspondence Received |
| 2023-05-23 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2023-05-14 | Application Extension To Response Period - Received |
| 2023-05-14 | Application Extension Granted/Receipt Provided |
| 2023-02-15 | Final Refusal Mailed |
| 2023-02-15 | Final Refusal E-Mailed |
| 2023-02-15 | Notification Of Final Refusal Emailed |
| 2022-11-15 | Correspondence Received In Law Office |
| 2022-11-15 | Teas/Email Correspondence Entered |
| 2022-11-10 | Assigned To Lie |
| 2022-09-28 | Teas Response To Office Action Received |
| 2022-04-06 | Non-Final Action Written |
| 2022-04-06 | Non-Final Action E-Mailed |
| 2022-04-06 | Notification Of Non-Final Action E-Mailed |
| 2022-03-28 | Assigned To Examiner |
| 2021-09-15 | New Application Office Supplied Data Entered |
| 2021-07-12 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders; Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of recombinant proteins; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders by modulating the immune system by recombinant proteins that contain a targeting moiety and an effector moiety t…
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 30 Jan 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.